- Published on 19 November 2015
US News Health takes a closer look at ototoxic medications and lists some of the commonly used active ingredients that are now known to potentially damage hearing.
Although the public is well aware that most drugs have side effects, especially given the long list of adverse reactions provided in package leaflets and television commercials that serve as a constant reminder, potential damage to hearing is not one of the better known risks. According to US News, more than 200 medications on the market today are known to be ototoxic.
Research has shown some risk of ototoxicity for certain very common over-the-counter medications, such as acetaminophen (paracetamol) and ibuprofen, used as analgesics and antipyretics. For these substances, frequency of use seems to be associated with more severe outcomes. In men, taking one of the most broadly used drugs, aspirin, twice or more per week may involve a higher risk of hearing loss. This effect is however thought to be reversible on treatment discontinuation.
The aminoglycoside antibiotic class of drugs, which includes for instance gentamicin and tobramycin, is well known for toxic effects on hearing. Alternatives are often preferred because of the risk of cochleotoxicity, which occurs through molecular mechanisms that are still poorly understood but that may result in permanent hearing loss. Some chemotherapy drugs can also lead to hearing impairments but when dealing with potentially life-threatening conditions, the benefit/risk ratio is much more difficult to establish. Examples include cisplatin or carboplatin.
Source: US News Health
The American Tinnitus Association (ATA) is to host a joint networking event with the British Tinnitus Association (BTA). The evening will take place on January 25, 2020 at the Association for Research in Otolaryngology (ARO) Mid-Winter Meeting in San Jose, California.
A call by academics to make earplugs obligatory at music events has turned up the noise on both sides of the argument in Belgium, following a study showing that 75% of events do not meet noise standards.
A pioneering recent study among Northern Territory (NT) aboriginal children in Australia has shown that preventable hearing impairment is negatively impacting their first years of primary school attendance.
The Italy-based hearing care retail company, Amplifon, has joined Europe's major manufacturing association, EHIMA.
Groups working to unite the UK hearing care profession under a College of Audiology have issued a joint response statement to the announced withdrawal from the process by the British Academy of Audiology (BAA). The remaining groups will push on, but have reached out to the BAA to return.[ ... ]
Stockpiling because of Brexit insecurity is behind Q3 unit sales for hearing aids in the UK repeating this year's Q1 pattern, a 12.9% rise on 2018, according to data from the British and Irish Hearing Instrument Manufacturers Association (BIHMI).
The 2019 Oticon Focus on People (FOP) Awards has honoured 13 people for their roles in showing that hearing loss does not limit a person's ability to live a full, productive, and inspiring life.
The Danish audiology software firm, Auditdata, has launched AuditdataOne, an all-in-one software platform that allows retail audiology to leverage data to improve operational performance and deliver better treatment outcomes.[ ... ]
As the global hearing care profession faces disruptive change, we think it is more imperative than ever that retail audiology businesses seize the opportunity to improve the way they manage and deliver their core services.[ ... ]